Loading clinical trials...
Loading clinical trials...
A Phase 1a, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of SYNT001 in Healthy Volunteers
Conditions
Interventions
SYNT001
Placebo
Locations
1
United States
Clinical Pharmacology of Miami
Miami, Florida, United States
Start Date
August 17, 2016
Primary Completion Date
April 13, 2017
Completion Date
April 13, 2017
Last Updated
August 24, 2018
NCT06716502
NCT00090662
NCT07310264
NCT06290258
NCT07483606
NCT06342713
Lead Sponsor
Syntimmune, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions